Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Affymetrix Charts. Click Here for more Affymetrix Charts.](/p.php?pid=staticchart&s=N%5EAFFX&p=8&t=15)
Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
SANTA CLARA, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Affymetrix, Inc. today
announced that it will present at the 22nd Annual JPMorgan Healthcare Conference
in San Francisco. A live transmission of the presentation will take place at
6:00 pm ET on Monday, January 12, 2004. An archived webcast will be available
for 30 days.
Affymetrix Founder, Chairman and Chief Executive Officer Stephen P.A. Fodor will
provide an overview of the company and outline future growth opportunities. To
access the live webcast or archived presentation, please go to
http://www.affymetrix.com/ and click on the "Investors" link.
About Affymetrix
Affymetrix is a pioneer in creating breakthrough tools that are driving the
genomic revolution. By applying the principles of semiconductor technology to
the life sciences, Affymetrix develops and commercializes systems that enable
scientists to improve the quality of life. The Company's customers include
pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products
companies, as well as academic, government, and other non-profit research
institutes. Affymetrix offers an expanding portfolio of integrated products and
services, including its integrated GeneChip(R) brand platform to address the
growing markets focused on understanding the relationship between genes and
human health. Additional information on Affymetrix may be found at
http://www.affymetrix.com/.
DATASOURCE: Affymetrix, Inc.
CONTACT: Doug Farrell, Vice President of Investor Relations,
+1-408-731-5285
Web site: http://www.affymetrix.com/